Acceptance of non-self: Decoding intestinal immune tolerance during early life
Project Number5DP2AI171116-03
Contact PI/Project LeaderBROWN, CHRYSOTHEMIS
Awardee OrganizationSLOAN-KETTERING INST CAN RESEARCH
Description
Abstract Text
Project Summary
Developing infants are colonized with trillions of bacteria within the intestine. Failure to establish tolerance within
a narrow early life window leads to increased risk of immune mediated diseases in later life, including chronic
inflammation and cancer. Central to the generation of intestinal tolerance is the peripheral conversion of naïve
T cells into regulatory T (pTreg) cells that suppress immune responses to commensal microbes. pTreg cells
arise in the intestine at the time of weaning; however, the cell types that instruct pTreg cell fate are not known,
limiting our ability to modulate pTreg cells for therapeutic benefit. We recently discovered a fascinating population
of antigen presenting cells (APC), enriched within the intestinal lymph nodes during early life. These cells,
dubbed Thetis cells (TCs), express the autoimmune regulator Aire, known for its critical role in immune tolerance.
Here we set forth the tantalizing possibility that TCs represent a dedicated lineage of tolerogenic APCs. We aim
to uncover their role in instructing pTreg cell fate in neonates, and susceptibility to inflammatory disease in later
life. Our proposed genetic models allow lineage-specific manipulation of TCs, including deletion of Aire. Through
these studies we aim to develop a deep mechanistic understanding of TC function. In our efforts to define the
biology of TCs, we seek to understand the ontogeny and development of these cells. Using state-of-the-art
lineage tracing approaches and genetic models that allow us to perturb the intestinal micro-environment in a
tissue- and developmental-stage-specific manner, we will dissect the cross-talk between stromal and immune
cells that drives tissue-specific early life immune development. The overarching goal of this proposal is to
establish a roadmap for intestinal immune tolerance, delineating the critical antigen presenting cells that direct
tolerance to commensal antigens, and the environmental cues that drive their differentiation. These studies will
i) provide an unprecedented view of early life immune development, ii) establish a new framework for peripheral
immune tolerance, and iii) reveal potential therapeutic targets for inflammatory and immune mediated diseases.
Public Health Relevance Statement
Project Narrative
The intestinal immune system has a unique ability to discriminate harmless commensal microbes from
pathogens, yet remarkably little is known about the cell types that initiate tolerance to commensal antigens at
the time of colonization in early life. A developmental wave of antigen-presenting cells (APCs) seeds the
intestine during the first week of life. This proposal seeks to determine how these APCs establish tolerance to
commensal microbiota, the tissue signals that drive their development, and their role in susceptibility to
intestinal immune mediated diseases in adulthood.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
064931884
UEI
KUKXRCZ6NZC2
Project Start Date
05-August-2022
Project End Date
31-July-2027
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$531,000
Direct Costs
$300,000
Indirect Costs
$231,000
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$531,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5DP2AI171116-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5DP2AI171116-03
Patents
No Patents information available for 5DP2AI171116-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5DP2AI171116-03
Clinical Studies
No Clinical Studies information available for 5DP2AI171116-03
News and More
Related News Releases
No news release information available for 5DP2AI171116-03
History
No Historical information available for 5DP2AI171116-03
Similar Projects
No Similar Projects information available for 5DP2AI171116-03